Insulin on Board Compensation for a Closed-Loop Insulin Infusion System
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 13 of these applications claim priority to application 61/694,950, filed Aug 30, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,999,728 | Regulating Entry into a Closed-Loop Operating Mode of an Insulin Infusion System In force · Low confidence UsedRemaining | Medtronic Minimed, Inc. | In force | Low confidence | ||
| US 11,986,633 | Sensor Model Supervisor for Temporary Reductions in Fluid Delivery by a Fluid Delivery Device In force · Low confidence | Medtronic Minimed, Inc. | In force | Low confidence | ||
| US 12,268,846 | Regulating Delivery of Insulin to a Body of a User by a Fluid Delivery Device In force · Medium confidence | Medtronic Minimed, Inc. | In force | Medium confidence | ||
| US 9,878,096 | Generation of Target Glucose Values for a Closed-Loop Operating Mode of an Insulin Infusion System In force · High confidence | Medtronic Minimed, Inc. | In force | High confidence | ||
| US 9,364,609 | Insulin on Board Compensation for a Closed-Loop Insulin Infusion System In force · High confidence | Medtronic Minimed, Inc. | In force | High confidence | ||
| US 9,526,834 | Safeguarding Measures for a Closed-Loop Insulin Infusion System In force · High confidence | Medtronic Minimed, Inc. | In force | High confidence | ||
| US 10,130,767 | Sensor Model Supervisor for a Closed-Loop Insulin Infusion System In force · Medium confidence | Medtronic Minimed, Inc. | In force | Medium confidence | ||
| US 9,662,445 | Regulating Entry into a Closed-Loop Operating Mode of an Insulin Infusion System In force · Low confidence | Medtronic Minimed, Inc. | In force | Low confidence | ||
| US 10,496,797 | Blood Glucose Validation for a Closed-Loop Operating Mode of an Insulin Infusion System In force · High confidence | Medtronic Minimed, Inc. | In force | High confidence | ||
| US 9,623,179 | Safeguarding Techniques for a Closed-Loop Insulin Infusion System In force · Low confidence | Medtronic Minimed, Inc. | In force | Low confidence | ||
| 6 more records in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16.
13 of these are in force and held by Medtronic Minimed, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.